Advertisement

Amino Acids

, Volume 50, Issue 6, pp 765–774 | Cite as

Taurine supplementation induces long-term beneficial effects on glucose homeostasis in ob/ob mice

  • Patricia Cristine BorckEmail author
  • Jean Franciesco Vettorazzi
  • Renato Chaves Souto Branco
  • Thiago Martins Batista
  • Junia Carolina Santos-Silva
  • Vanessa Yumi Nakanishi
  • Antonio Carlos Boschero
  • Rosane Aparecida Ribeiro
  • Everardo Magalhães Carneiro
Original Article

Abstract

The sulfur-containing amino acid, taurine (Tau), regulates glucose and lipid homeostasis under normal, pre- and diabetic conditions. Here, we aimed to verify whether Tau supplementation exerts its beneficial effects against obesity, hyperglycemia and alterations in islet functions, in leptin-deficient obese (ob/ob), over a long period of treatment. From weaning until 12 months of age, female ob/ob mice received, or not, 5% Tau in drinking water (obTau group). After this period, a reduction in hypertriglyceridemia and an improvement in glucose tolerance and insulin sensitivity were observed in obTau mice. In addition, the daily metabolic flexibility was restored in obTau mice. In the gastrocnemius muscle of obTau mice, the activation of AMP-activated protein kinase (AMPK) was increased, while total AMPK protein content was reduced. Finally, isolated islets from obTau mice expressed high amounts of pyruvate carboxylase (PC) protein and lower glucose-induced insulin secretion. Taking these evidences together Tau supplementation had long-term positive actions on glucose tolerance and insulin sensitivity, associated with a reduction in glucose-stimulated insulin secretion, in ob/ob mice. The improvement in insulin actions in obTau mice was due, at least in part, to increased activation of AMPK in skeletal muscle, while the increased content of the PC enzyme in pancreatic islets may help to preserve glucose responsiveness in obTau islets, possibly contributing to islet cell survive.

Keywords

Aging AMP-activated protein Insulin secretion Metabolic flexibility ob/ob mice Pyruvate carboxylase 

Notes

Acknowledgements

The authors thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and Conselho Nacional para o Desenvolvimento Científico e Tecnológico (CNPq) for supporting the research. The authors also thank Marise Carnelossi Brunelli for excellent technical assistance and Nicola Conran for editing English.

Author contributions

PCB, RAR, ECM designed research; PCB, TMB, JFV, RCSB, JCSS, VYN conducted the experiments and acquired data; PCB, RAR analyzed data and performed statistical analysis; ACB, EMC acquired the reagents; PCB, RAR wrote the manuscript; JFV, ACB, EMC revised the manuscript; PCB, RAR, EMC had responsibility for final content.

Funding

This study was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2014/01717-9; 2015/12611-0), Conselho Nacional para o Desenvolvimento Científico e Tecnológico (CNPq 449794/2014-8).

Compliance with ethical standards

Conflict of interest

All contributing authors declare no conflicts of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

References

  1. Alberts P, Johansson BG, McArthur RA (2006) Characterization of energy expenditure in rodents by indirect calorimetry. Curr Protoc Neurosci Chapter 9(9):23.  https://doi.org/10.1002/0471142301.ns0923ds36 Google Scholar
  2. Ando H, Kumazaki M, Motosugi Y, Ushijima K, Maekawa T, Ishikawa E, Fujimura A (2011) Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 152:1347–1354.  https://doi.org/10.1210/en.2010-1068 CrossRefPubMedGoogle Scholar
  3. Batista TM, Ribeiro RA, da Silva PM, Camargo RL, Lollo PC, Boschero AC, Carneiro EM (2013) Taurine supplementation improves liver glucose control in normal protein and malnourished mice fed a high-fat diet. Mol Nutr Food Res 57:423–434.  https://doi.org/10.1002/mnfr.201200345 CrossRefPubMedGoogle Scholar
  4. Bergeron R, Russell RR 3rd, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI (1999) Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 276:E938–944CrossRefPubMedGoogle Scholar
  5. Bonfleur ML, Borck PC, Ribeiro RA, Caetano LC, Soares GM, Carneiro EM, Balbo SL (2015) Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. Life Sci 135:15–21.  https://doi.org/10.1016/j.lfs.2015.05.019 CrossRefPubMedGoogle Scholar
  6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
  7. Branco RC et al (2015) Long-term taurine supplementation leads to enhanced hepatic steatosis, renal dysfunction and hyperglycemia in mice fed on a high-fat diet. Adv Exp Med Biol 803:339–351.  https://doi.org/10.1007/978-3-319-15126-7_26 CrossRefPubMedGoogle Scholar
  8. Di Leo MA, Santini SA, Silveri NG, Giardina B, Franconi F, Ghirlanda G (2004) Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats. Amino Acids 27:187–191.  https://doi.org/10.1007/s00726-004-0108-2 CrossRefPubMedGoogle Scholar
  9. Figueroa AL, Figueiredo H, Rebuffat SA, Vieira E, Gomis R (2016) Taurine treatment modulates circadian rhythms in mice fed a high fat diet. Sci Rep 6:36801.  https://doi.org/10.1038/srep36801 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Gong Z, Muzumdar RH (2012) Pancreatic function, type 2 diabetes, and metabolism in aging. Int J Endocrinol 2012:320482.  https://doi.org/10.1155/2012/320482 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA (2002) Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun 294:798–805.  https://doi.org/10.1016/S0006-291X(02)00557-0 CrossRefPubMedGoogle Scholar
  12. Han J, Liu YQ (2010) Reduction of islet pyruvate carboxylase activity might be related to the development of type 2 diabetes mellitus in Agouti-K mice. J Endocrinol 204:143–152.  https://doi.org/10.1677/JOE-09-0391 CrossRefPubMedGoogle Scholar
  13. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163CrossRefPubMedGoogle Scholar
  14. Hwa JJ, Ghibaudi L, Compton D, Fawzi AB, Strader CD (1996) Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice. Horm Metab Res 28:659–663.  https://doi.org/10.1055/s-2007-979873 CrossRefPubMedGoogle Scholar
  15. Hwa JJ et al (1997) Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 272:R1204–1209PubMedGoogle Scholar
  16. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW (2006) Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290:R894–903.  https://doi.org/10.1152/ajpregu.00304.2005 CrossRefPubMedGoogle Scholar
  17. Lee JH et al (2014) Toxicity generated through inhibition of pyruvate carboxylase and carnitine palmitoyl transferase-1 is similar to high glucose/palmitate-induced glucolipotoxicity in INS-1 beta cells. Mol Cell Endocrinol 383:48–59.  https://doi.org/10.1016/j.mce.2013.12.002 CrossRefPubMedGoogle Scholar
  18. Liu YQ, Jetton TL, Leahy JL (2002) beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem 277:39163–39168.  https://doi.org/10.1074/jbc.M207157200 CrossRefPubMedGoogle Scholar
  19. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217.  https://doi.org/10.1016/j.cell.2013.05.039 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Murakami S, Kondo Y, Nagate T (2000) Effects of long-term treatment with taurine in mice fed a high-fat diet: improvement in cholesterol metabolism and vascular lipid accumulation by taurine. Adv Exp Med Biol 483:177–186.  https://doi.org/10.1007/0-306-46838-7_19 CrossRefPubMedGoogle Scholar
  21. Muzzin P, Eisensmith RC, Copeland KC, Woo SL (1996) Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci USA 93:14804–14808CrossRefPubMedPubMedCentralGoogle Scholar
  22. Nandhini AT, Thirunavukkarasu V, Anuradha CV (2005) Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 31:337–344CrossRefPubMedGoogle Scholar
  23. Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL (2015) Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64:2289–2298.  https://doi.org/10.2337/db14-1820 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Ribeiro RA, Vanzela EC, Oliveira CA, Bonfleur ML, Boschero AC, Carneiro EM (2010) Taurine supplementation: involvement of cholinergic/phospholipase C and protein kinase A pathways in potentiation of insulin secretion and Ca2 + handling in mouse pancreatic islets. Br J Nutr 104:1148–1155.  https://doi.org/10.1017/S0007114510001820 CrossRefPubMedGoogle Scholar
  25. Ribeiro RA, Santos-Silva JC, Vettorazzi JF, Cotrim BB, Mobiolli DD, Boschero AC, Carneiro EM (2012) Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic beta-cells. Amino Acids 43:1791–1801.  https://doi.org/10.1007/s00726-012-1263-5 CrossRefPubMedGoogle Scholar
  26. Santos-Silva JC et al (2015) Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls beta, alpha, and delta-cell masses in genetic obese mice. Amino Acids 47:1533–1548.  https://doi.org/10.1007/s00726-015-1988-z CrossRefPubMedGoogle Scholar
  27. Schuit F, De Vos A, Farfari S, Moens K, Pipeleers D, Brun T, Prentki M (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572–18579CrossRefPubMedGoogle Scholar
  28. Stockebrand M, Sauter K, Neu A, Isbrandt D, Choe CU (2013) Differential regulation of AMPK activation in leptin- and creatine-deficient mice. FASEB J Off Publ Fed Am Soc Exp Biol 27:4147–4156.  https://doi.org/10.1096/fj.12-225136 Google Scholar
  29. Strohmayer AJ, Smith GP (1987) The meal pattern of genetically obese (ob/ob) mice. Appetite 8:111–123CrossRefPubMedGoogle Scholar
  30. Sugden MC, Holness MJ (2011) The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: going round in circles? Islets 3:302–319.  https://doi.org/10.4161/isl.3.6.17806 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Szewczyk-Golec K, Wozniak A, Reiter RJ (2015) Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity. J Pineal Res 59:277–291.  https://doi.org/10.1111/jpi.12257 CrossRefPubMedGoogle Scholar
  32. Takahashi Y, Tamura Y, Matsunaga Y, Kitaoka Y, Terada S, Hatta H (2016) Effects of taurine administration on carbohydrate metabolism in skeletal muscle during the post-exercise phase. J Nutr Sci Vitaminol 62:257–264.  https://doi.org/10.3177/jnsv.62.257 CrossRefPubMedGoogle Scholar
  33. Tomita T, Doull V, Pollock HG, Krizsan D (1992) Pancreatic islets of obese hyperglycemic mice (ob/ob). Pancreas 7:367–375CrossRefPubMedGoogle Scholar
  34. Treebak JT et al (2006) AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes 55:2051–2058.  https://doi.org/10.2337/db06-0175 CrossRefPubMedGoogle Scholar
  35. Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276–3284.  https://doi.org/10.1210/en.2005-1007 CrossRefPubMedGoogle Scholar
  36. Wang W, Liu C, Jimenez-Gonzalez M, Song WJ, Hussain MA (2017) The undoing and redoing of the diabetic beta-cell. J Diabetes Comp.  https://doi.org/10.1016/j.jdiacomp.2017.01.028 Google Scholar
  37. Zachariah Tom R et al (2014) Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice. Diabetes 63:1560–1571.  https://doi.org/10.2337/db13-0670 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Patricia Cristine Borck
    • 1
    Email author
  • Jean Franciesco Vettorazzi
    • 1
  • Renato Chaves Souto Branco
    • 1
  • Thiago Martins Batista
    • 1
  • Junia Carolina Santos-Silva
    • 1
  • Vanessa Yumi Nakanishi
    • 1
  • Antonio Carlos Boschero
    • 1
  • Rosane Aparecida Ribeiro
    • 2
  • Everardo Magalhães Carneiro
    • 1
  1. 1.Laboratory of Pancreas Endocrine and Metabolism, Obesity and Comorbidities Research Center, Institute of BiologyUniversity of Campinas/UNICAMPCampinasBrazil
  2. 2.Universidade Federal do Rio de JaneiroMacaéBrazil

Personalised recommendations